VIGIP-SEP2: Evaluation of the Impact of the Training of Patients by a Nurse on the Adverse Drug Reaction Reporting by RRMS Patient Via a Mobile Application: Randomized Real-life Study
Launched by UNIVERSITY HOSPITAL, CAEN · Oct 3, 2019
Trial Information
Current as of May 10, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • more than 18 years
- • multiple sclerosis in initiation with a DMT
- • patient informed and who gave informed consent
- Exclusion Criteria:
- • patient without mobile or tablet
About University Hospital, Caen
The University Hospital of Caen is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent center for medical education and patient care in Normandy, France, it integrates cutting-edge scientific inquiry with compassionate clinical practice. The hospital collaborates with multidisciplinary teams to conduct rigorous studies aimed at improving treatment outcomes across various medical specialties. By fostering a collaborative environment, the University Hospital of Caen plays a pivotal role in translating research findings into effective therapeutic strategies, ultimately enhancing patient care and contributing to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials